AZTherapies

AZTherapies

Clinical stage biotech company developing breakthrough treatments for neuroinflammation-related diseases.

Launch date
Employees
Market cap
-
Enterprise valuation
AUD163—244m (Dealroom.co estimates Oct 2019.)
Boston Massachusetts (HQ)
Authorizing premium user...